Tetanus Toxoid
Pertussis
National Institute of Allergy and Infectious Diseases (NIAID)vaccinePhase 3Dormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Pertussis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Dtp Vaccine National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 | BB |
Whole-Cell Pertussis Vaccine National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 | BB |
HUMAN IMMUNOGLOBULINS IWK Health Centre | Phase 3 | B |
Same molecule, other indications
Tetanus Toxoid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →